Coave Therapeutics
Targeted gene therapies for rare diseases
- B2B
About Coave Therapeutics
Developing innovative gene therapies for rare ocular and CNS diseases using a unique platform for targeted delivery and enhanced effectiveness.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2014
- Revenue
- $7.9M – $62.2MTamtam estimate
- Website
- coavetx.com
- linkedin.com/company/coavetx
Coave Therapeutics at a glance
Coave Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Coave Therapeutics was founded in 2014.
Coave Therapeutics has 51–250 employees.
Coave Therapeutics's revenue is $7.9M – $62.2M (Tamtam estimate).
Selling to companies like Coave Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies